For research use only. Not for therapeutic Use.
Salazopyridazine(Cat No.:I042923)is a medication primarily used for its anti-inflammatory and immunosuppressive effects, particularly in the treatment of autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease (IBD). It is a prodrug of sulfapyridine and works by inhibiting the production of pro-inflammatory cytokines and immune system responses. Salazopyridazine is structurally similar to sulfasalazine, another drug used for similar conditions, but it has a distinct pharmacological profile. It is being studied for its potential to manage conditions involving chronic inflammation and immune dysfunction, with ongoing research exploring its broader therapeutic applications in autoimmune disorders.
CAS Number | 22933-72-8 |
Synonyms | 2-hydroxy-5-[[4-[(6-methoxypyridazin-3-yl)sulfamoyl]phenyl]diazenyl]benzoic acid |
Molecular Formula | C18H15N5O6S |
Purity | ≥95% |
IUPAC Name | 2-hydroxy-5-[[4-[(6-methoxypyridazin-3-yl)sulfamoyl]phenyl]diazenyl]benzoic acid |
InChI | InChI=1S/C18H15N5O6S/c1-29-17-9-8-16(21-22-17)23-30(27,28)13-5-2-11(3-6-13)19-20-12-4-7-15(24)14(10-12)18(25)26/h2-10,24H,1H3,(H,21,23)(H,25,26) |
InChIKey | YFUATOCFMCWUEH-UHFFFAOYSA-N |
SMILES | COC1=NN=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O |